1. Home
  2. STWD vs BLTE Comparison

STWD vs BLTE Comparison

Compare STWD & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

STWD

STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

HOLD

Current Price

$15.67

Market Cap

6.2B

Sector

Real Estate

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$173.05

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STWD
BLTE
Founded
2009
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.0B
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
STWD
BLTE
Price
$15.67
$173.05
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$20.00
$198.00
AVG Volume (30 Days)
3.6M
198.1K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
10.64%
N/A
EPS Growth
4.55
N/A
EPS
0.15
N/A
Revenue
$1,844,289,000.00
N/A
Revenue This Year
$283.44
N/A
Revenue Next Year
$17.66
$492.11
P/E Ratio
$105.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.49
$65.00
52 Week High
$20.62
$200.00

Technical Indicators

Market Signals
Indicator
STWD
BLTE
Relative Strength Index (RSI) 37.60 54.90
Support Level $15.50 $167.80
Resistance Level $16.89 $182.61
Average True Range (ATR) 0.26 7.90
MACD -0.02 2.18
Stochastic Oscillator 10.48 48.43

Price Performance

Historical Comparison
STWD
BLTE

About STWD STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

Starwood Property Trust Inc is a real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans, commercial mortgage-backed securities, and other real estate investments in the U.S., Australia, and Europe. The company has four reportable business segments: Commercial and Residential Lending, Infrastructure Lending, Property, and Investing and Servicing. The majority of its revenue is generated from the Commercial and Residential Lending segment, which engages mainly in originating, acquiring, financing, and managing commercial first mortgages, non-agency residential mortgages (residential loans), commercial mortgage-backed securities (CMBS), residential mortgage-backed securities (RMBS), and other real estate and related debt investments.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Share on Social Networks: